Clinical Trials on 早期乳腺癌 in China
总计1701个结果
-
Peking UniversityMerck Sharp & Dohme LLC; Cancer Institute and Hospital, Chinese Academy of Medical Sciences; Guangdong... 和其他合作者招聘中
-
National Cancer Institute (NCI)NRG Oncology主动,不招人不可切除的乳腺癌 | IV 期乳腺癌 AJCC v6 和 v7 | III 期乳腺癌 AJCC v7 | 转移性乳腺癌 | 转移性 HER2 阳性乳腺癌 | 复发性乳腺癌 | 复发性 HER2 阳性乳腺癌 | 不可切除的 HER2 阳性乳腺癌美国, 加拿大
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.招聘中
-
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.招聘中
-
Ying Lin招聘中Her-2 阴性乳腺癌 | HRR基因突变中国
-
First Affiliated Hospital of Zhejiang University招聘中
-
Cancer Institute and Hospital, Chinese Academy...招聘中
-
Cancer Institute and Hospital, Chinese Academy...Shanxi Province Cancer Hospital; Wuhan University; Peking Union Medical College Hospital; West China... 和其他合作者招聘中
-
Beijing Biostar Pharmaceuticals Co., Ltd.Chengdu Biostar Pharmaceuticals完全的
-
Sun Yat-sen UniversityHunan Cancer Hospital; Beijing Biostar Pharmaceuticals Co., Ltd.招聘中
-
Fourth Affiliated Hospital of Guangxi Medical UniversityLiuzhou Maternity and Child Healthcare Hospital; Liuzhou Hospital of Traditional Chinese Medicine未知
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University招聘中
-
Second Affiliated Hospital of Guangzhou Medical...招聘中
-
Shanghai University of Traditional Chinese MedicineJiangsu Province Hospital of Traditional Chinese Medicine; RenJi Hospital完全的
-
Peking University First Hospital招聘中
-
Jiangsu HengRui Medicine Co., Ltd.招聘中
-
Fudan UniversityChongqing University Cancer Hospital; Sun Yat-sen University; Peking University Cancer Hospital... 和其他合作者招聘中
-
The First Affiliated Hospital with Nanjing Medical...未知阿帕替尼联合白蛋白紫杉醇和卡铂方案用于三阴性乳腺癌新辅助治疗的 pCR 率的系统评价中国
-
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.主动,不招人
-
Zhujiang Hospital未知肿瘤 | IB 期宫颈癌 | IIA期宫颈癌 | IIB期宫颈癌 | III期宫颈癌 | IVA 期宫颈癌 | 宫颈腺鳞癌 | 宫颈鳞状细胞原位癌中国
-
The First Affiliated Hospital of Xinxiang Medical...AstraZeneca招聘中
-
The Affiliated Hospital of Qingdao University招聘中